Endocan Corp ENELIM Bond

ENDO Stock  USD 0.0001  0.00  0.00%   
Endocan Corp's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Endocan Corp's financial risk is the risk to Endocan Corp stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
  
Check out the analysis of Endocan Corp Fundamentals Over Time.
View Bond Profile
Given the importance of Endocan Corp's capital structure, the first step in the capital decision process is for the management of Endocan Corp to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Endocan Corp to issue bonds at a reasonable cost.
Popular NameEndocan Corp ENELIM 68 14 OCT 25
Equity ISIN CodeUS29271J1097
Bond Issue ISIN CodeUS29278GAZ19
S&P Rating
Others
Maturity DateOthers
Issuance DateOthers
View All Endocan Corp Outstanding Bonds

Endocan Corp Outstanding Bond Obligations

Dana 575 percentUS235822AB96Details
Volcan Compania MineraUSP98047AC08Details
Boeing Co 2196US097023DG73Details
ENERGY TRANSFER PARTNERSUS29273RAP47Details
ENERGY TRANSFER PARTNERSUS29273RAR03Details
ENERGY TRANSFER PARTNERSUS29273RAJ86Details
ENERGY TRANSFER PARTNERSUS29273RAZ29Details
ENERGY TRANSFER PARTNERSUS29273RAT68Details
ET 783107 01 NOV 66US29273RBA68Details
ENERGY TRANSFER PARTNERSUS29273RBC25Details
ENERGY TRANSFER PARTNERSUS29273RBD08Details
ENERGY TRANSFER PARTNERSUS29273RBJ77Details
ET 555 15 FEB 28US29273VAP58Details
ENERGY TRANSFER PARTNERSUS29273RBK41Details
ET 575 15 FEB 33US29273VAQ32Details
ENERGY TRANSFER PARTNERSUS29273RBL24Details
ENERGY TRANSFER PARTNERSUS29273RBE80Details
ET 675US29273VAL45Details
ENERGY TRANSFER PARTNERSUS29273RBF55Details
Energy Transfer 7125US29273VAM28Details
ENERGY TRANSFER PARTNERSUS29273RBG39Details
US29273VAN01US29273VAN01Details
ENERGY TRANSFER OPERUS29278NAG88Details
ENERGY TRANSFER OPERUS29278NAD57Details
ENERGY TRANSFER OPERUS29278NAE31Details
ENERGY TRANSFER OPERUS29278NAF06Details
ENERGY TRANSFER OPERATINGUS29278NAQ60Details
ENERGY TRANSFER PARTNERSUS29273RAF64Details
ENERGY TRANSFER OPERATINGUS29278NAR44Details
ENERGY TRANSFER OPERATINGUS29278NAP87Details
ENERGY TRANSFER OPERATINGUS29278NAN30Details
HSBC Holdings PLCUS404280DR76Details
ENERGIZER HLDGS INCUS29272WAD11Details
ENERGIZER HLDGS INCUS29272WAC38Details
US29279XAA81US29279XAA81Details
US29272WAF68US29272WAF68Details
MPLX LP 52US55336VAL45Details
ENEL CHILE SUS29278DAA37Details
EnerSys 4375 percentUS29275YAC66Details
ENEL AMERICAS SUS29274FAF18Details
ENERGY TRANSFER OPERUS29279FAA75Details
ENELIM 3625 25 MAY 27US29278GAA67Details
ENELIM 4875 14 JUN 29US29278GAK40Details
ENELIM 35 06 APR 28US29278GAF54Details
ENELIM 475 25 MAY 47US29278GAC24Details
ENELIM 225 12 JUL 31US29278GAP37Details
ENELIM 1875 12 JUL 28US29278GAN88Details
Morgan Stanley 3591US61744YAK47Details
ENELIM 1375 12 JUL 26US29278GAM06Details
ENELIM 55 15 JUN 52US29278GAY44Details
ENELIM 68 14 OCT 25US29278GAZ19Details
ENELIM 4625 15 JUN 27US29278GAW87Details
ENELIM 5 15 JUN 32US29278GAX60Details
ENELIM 425 15 JUN 25US29278GAV05Details
ENELIM 775 14 OCT 52US29278GBB32Details
ENELIM 75 14 OCT 32US29278GBA58Details

Understaning Endocan Corp Use of Financial Leverage

Leverage ratios show Endocan Corp's total debt position, including all outstanding obligations. In simple terms, high financial leverage means that the cost of production, along with the day-to-day running of the business, is high. Conversely, lower financial leverage implies lower fixed cost investment in the business, which is generally considered a good sign by investors. The degree of Endocan Corp's financial leverage can be measured in several ways, including ratios such as the debt-to-equity ratio (total debt / total equity), or the debt ratio (total debt / total assets).
Thermic Sciences International develops and sells hemp based products. Thermic Sciences International was incorporated in 1969 and is based in Colorado Springs, Colorado. ENDOCAN CORP operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange.
Please read more on our technical analysis page.

Pair Trading with Endocan Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Endocan Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endocan Corp will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Endocan Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Endocan Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Endocan Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Endocan Corp to buy it.
The correlation of Endocan Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Endocan Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Endocan Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Endocan Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Endocan Pink Sheet

Endocan Corp financial ratios help investors to determine whether Endocan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endocan with respect to the benefits of owning Endocan Corp security.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.